View
2
Download
0
Category
Preview:
Citation preview
Supplementary information
Title
Neuroprotection and lifespan extension in Ppt1-/-mice by NtBuHA: therapeutic implications for INCL
Authors
Chinmoy Sarkar, Goutam Chandra, Shyiong Peng, Zhongjian Zhang, Aiyi Liu and Anil B. Mukherjee
Nature Neuroscience: doi:10.1038/nn.3526
Plasma membrane
Endolysosome
PPT1-deficientNormal
Failure ofdepalmitoylation
Lysosomalstorage of ceroid
Degradationproducts
Protein
Palmitate
Supplementary data Fig. 1. In normal cells, the membrane-anchored palmitoylated proteins are depalmitoylated by lysosomal PPT1 and degraded by lysosomal hydrolases clearing the lysosomes. However in PPT1-deficient (INCL) cells failure of depalmitoylation makes these proteins refractory to lysosomal hydrolases. Consequently, accumulation of the palmitoylated proteins leads to lysosomal storage of ceroid causing INCL pathogenesis.
Supplementary Fig. 1 Schematic depiction of the mechanism of ceroid accumulation in INCL.
Nature Neuroscience: doi:10.1038/nn.3526
Supplementary data Fig. 2 INCL fibroblasts were incubated with increasing concentrations of (a) N-t-butyl hydroxylamine, (b) N-benzylhydroxylamine, (c) N-Methyl hydroxylamine, (d) N-cyclohexyl hydroxylamine, (e) N-benzyloxycarbonyl hydroxylamine, (f) N,N-dimethyl hydroxylamine, (g) N,N-diethyl hydroxylamine, (h) N-benzoyl-N-phenyl hydroxylamine, (i) N,O-bis(trimethylsilyl) hydroxylamine, (j) N,O-Di-BOC hydroxylamine for 48 hours. Viability of the treated cells was estimated by MTT assay (see method section). Note that most of the derivatives are nontoxic up to 1 mM concentration. * P<0.05.
a
c
e
g
i j
h
f
d
b
NtBuHA (mM)
0
50
100
150
Control 0.1 0.5 1 2.5
Via
bili
ty (
%co
ntr
ol)
N-benzylHA (mM)
020406080
100120140
Control 0.1 0.5 1 2.5
Via
bili
ty (
%co
ntr
ol)
N-methylHA (mM)
0
20
40
60
80
100
120
Control 0.1 0.5 1 2.5
Via
bili
ty (
% c
on
tro
l)
N-cyclohexylHA (mM)
020406080
100120140
Control 0.1 0.5 1 2.5
Via
bili
ty (
% c
on
tro
l)
N-benzyloxycarbonylHA (mM)
020406080
100120140
Control 0.1 0.5 1 2.5
Via
bili
ty (
% c
on
tro
l)
N,N-dimethyl HAControl 0.1 0.5 1 2.5
0
50
100
150
200
Via
bili
ty (
% c
on
tro
l)
N,N-diethyl HA (mM)
020406080
100120140
Control 0.1 0.5 1 2.5
Via
bili
ty (
% c
on
tro
l)
N-benzoyl-N-phenyl HA (mM)
020406080
100120
Control 0.1 0.5 1 2.5
Via
bili
ty (
% c
on
tro
l)
N,O-bis(trimethylsilyl) HA (mM)
0
50
100
150
Control 0.1 0.5 1 2.5
Via
bili
ty (
% c
on
tro
l)
N,O-Di-BOC-HA (mM)
0
50
100
150
200
Control 0.1 0.5 1 2.5
Via
bili
ty (
% c
on
tro
l)
* *
*
Supplementary Fig. 2. Effect of hydroxylamine derivatives on viability of INCL fibroblasts.
Nature Neuroscience: doi:10.1038/nn.3526
Supplementary Fig. 3 Viability of INCL lymphoblasts treated with NtBuHA: Time Course and plating efficiency of NtBuHA treated INCL fibroblasts.
Supplementary data Fig 3. (a). Lymphoblasts isolated from INCL patients were cultured for varying length of time in presence of 500 µM NtBuHA. Viability of those cells at the end of incubation period was estimated by MTT assay and expressed as percent of viability of untreated control. The data is presented as the mean of three independent experiments ±SD. (b). Skin fibroblasts from an INCL patient were treated with varying doses (0 to 2.5 mM) of NtBuHA for 48 h. At the end of the treatment period the cells were trypsinized and re-plated at a density of 100 cells per plate. The colonies formed from 100 cells in more than 10 replicates for each treatment were stained with Crystal violet, air dried and photographed.
0
20
40
60
80
100
120
140
0 12 24 36 48 60
Time (h)
Via
bilit
y (
% c
ontr
ol)
Control 0.1 mM NtBuHA 0.5 mM NtBuHA
1 mM NtBuHA 2.5 mM NtBuHA
a
b
Nature Neuroscience: doi:10.1038/nn.3526
a. b.
1 2 3 4 5 6
Time course
0
5000
10000
15000
20000
25000
30000
35000
40000
0 10 50 100 250 500
NtBuHA (uM)
Den
sity
(IN
Tpe
rm
m2 )
Dose response
1 2 3 4 5 6 7
0
10000
20000
30000
40000
50000
60000
0 15 30 60 120
Time (m)
Den
sity
(IN
T p
er m
m2 )
Supplementary Fig. 4 NtBuHA-mediated cleavage of thioester linkage in [14C] PalmitoylCoA.
Supplementary data Fig. 4 (a) Dose-response: The release of free [14C]palmitic acid from [14C] palmitoyl CoA by varying doses of NtBuHA at room temperature for 1 h. Lanes: (1) [14C]palmitic acid standard; (2) [14C]-palmitoyl CoA standard; (3) 10 µM NtBuHA; (4) 50 µM NtBuHA; (5) 100 µM NtBuHA; (6) 250 µM NtBuHA and (7) 500 µM NtBuHA. (b) Time-course of [14C]-palmitic acid release from [14C] palmitoyl CoA by 500 µM of NtBuHA. Lanes: (1) [14C]palmitic acid standard; (2) 0 min; (3) 15 min; (4) 30 min; (5) 60 min; (6) 120 min. Arrows indicate free [14C]Palmitate released. The densitometricquantitation of free [14C]palmitate bands are shown graphically below the autoradiographsof the TLCs (n=3). Note that the release of [14C]palmitate from [14C]-palmitoyl CoA by NtBuHA is dose- and time-dependent. The results were analyzed using student t test and P<0.01 was considered significant (in panel a) and P<0.05 in panel b at 60 and 120 minutes.
Nature Neuroscience: doi:10.1038/nn.3526
Supplementary Fig. 5 Densitometric quantitations of lipid thioester bands in untreated-and NtBuHA-treated INCL lymphoblasts.
Supplementary data Fig. 5 (a). [35S]Cysteine-labeled lipid thioester bands resolved by TLC as shown in Figure 1f. Eight bands were readily identifiable (arrows) and marked as bands 1 to 8 (from the top). The density of each of these bands from untreated and NtBuHA-treated INCL patients’ cells were quantified using QuantityOne software (Biorad). The densitometric data are presented as the mean intensity/mm2 (INT/mm2) from three independent experiments ±SD. (b). [35S]Cysteine-labeled lipid thioester bands in untreated and NtBuHA-treated lymphoblasts from 9 INCL patients are resolved by TLC as shown in Figure 1g (right panel). Each of the 8 readily identifiable bands as indicated in Fig.1f was marked as bands 1 to 8 (from the top). The results of densitometric quantitation are presented as the mean of 3 independent experiments ±SD.
0 10000
20000
30000
40000
50000
60000
band 1
band 2
band 3
band 4
band 5
band 6
band 7
band 8
Normal
INCL
INCL- NtBuHA
P<0.05
P<0.01
P<0.05
P<0.05
P<0.01
P<0.01
Density (INT per mm2)
0 5000 10000 15000 20000 25000 30000 35000 40000 45000
band8
band7
band6
band5
band4
band3
band2
band1
Density (INT per mm2)
12h NtBuHA
12h Control
24h NtBuHA
24h Control
48h NtBuHA
48h Control
a b
Nature Neuroscience: doi:10.1038/nn.3526
a.
b.
Unt
reat
ed c
ontr
olN
tBuH
A-t
reat
edMagnified inset
c.
0
50
100
150
200
250
Untreated control NtBuHA treated
Num
ber
of G
RO
Ds
per
cell P<0.0001
Supplementary Fig. 6 Depletion of GRODs in INCL fibroblasts after treatment with NtBuHA.
Supplementary data Fig. 6 INCL fibroblast cells were treated without (a) or with (b) 250 µM of NtBuHA for 3 weeks. Cells were then fixed in 2.5% glutaraldehyde and processed for electron microscopy. The number of GRODs/cell from untreated- (n=7) and NtBuHA-treated (n=10) INCL fibroblasts are graphically represented in panel c. Note a clear reduction in GROD level in INCL cells treated with NtBuHA. Scale bar: 1µm.
Nature Neuroscience: doi:10.1038/nn.3526
Supplementary Fig. 7 Western blot analyses of ER- and oxidative stress markers in WT and Ppt1-/- mouse brains.
Grp94
0
1
2
WT
Rel
ativ
e de
nsity
Grp78
0
2
4
Rel
ativ
e de
nsity
ATF6
0
2
4
SOD2
0
1
2
Catalase
0
2
4
WT
WT
Untre
ated
-Ppt1-/-
WT
WT
Rel
ativ
e de
nsity
Rel
ativ
e de
nsity
Rel
ativ
e de
nsity
P<0.01 P<0.01P<0.01 P<0.01
P<0.01 p<0.01 P<0.01 P<0.01P<0.01 P<0.01
NuBuH
A-trea
ted-Ppt1-/-
Untre
ated
-Ppt1-/-
NuBuH
A-trea
ted-Ppt1-/-
Untre
ated
-Ppt1-/-
NuBuH
A-trea
ted-Ppt1-/-
Untre
ated
-Ppt1-/-
NuBuH
A-trea
ted-Ppt1-/-
Untre
ated
-Ppt1-/-
NuBuH
A-trea
ted-Ppt1-/-
1 2 3 1 2 3 1 2 3
β‐actin
Catalase
SOD 2
ATF 6
Grp 78
Grp 94
WTUntreated Ppt1/-
NtBuHA-treated Ppt1-/-
Supplementary data Fig. 7 Cortical tissue homogenates prepared from 6-month old WT, untreated-Ppt1-/-
and NtBuHA-treated Ppt1-/- mice (n=6 in each group) were analyzed for ER-stress markers: ATF6, Grp94 and Grp78 and oxidative stress-markers: SOD2 and catalase, respectively. The results of densitometricquantitation of the protein bands (mean +SDs) are represented in the bar graphs.
Nature Neuroscience: doi:10.1038/nn.3526
Supplementary Fig. 8 Protection of superficial and deep cortical neurons of Ppt1-/-
mice by NtBuHA.
10 µm100 µm
Cux1 Ctip2 DAPI Merge Cux1/DAPI Ctip2/DAPI
WT
NtB
uHA
-tre
ated
-Ppt1-/
-
100 µm
100 µm
10 µm
10 µm
II&III
IV
V
VI
VI
VI
V
V
III&III
IV
II&III
IV
a b
c d
I
I
0
5
10
15
20
25
Num
ber
of C
ux1-
posi
tive
Cel
ls p
er 0
.01m
m2
0
5
10
Num
ber
of C
tip2-
posi
tive
Cel
ls p
er 0
.01m
m2P<0.05
P<0.05
P<0.05 P<0.05
Unt
reat
ed-Ppt1-/
-
WT Untreated Ppt1-/-
NtBuHA-treated Ppt1-/-
WT Untreated Ppt1-/-
NtBuHA-treated Ppt1-/-
Supplementary data Fig. 8 Superficial (II-IV) and deep (IV-VI) cortical layers of WT (a; upper panel),untreated Ppt1-/- (a; middle panel), and NtBuHA-treated Ppt1-/- (a; lower panel) brain sections were immunostained with Cux1 and Ctip2 respectively. For each group, representative images of Cux1 and Ctip2 –positive cells in layers II & III and layer V respectively are shown (b). Quantification of Cux1- (c) and Ctip2- (d) positive cells per 0.01 mm2 in these layers revealed significant protection of both these cells in NtBuHA-treated Ppt1-/- mice over their untreated littermates (n=4).
Nature Neuroscience: doi:10.1038/nn.3526
Supplementary Fig. 9 Cortical thickness in WT, untreated- and NtBuHA-treated Ppt1-/- mice; evaluation of motor coordination by rotarod rest in 3-month old WT and Ppt1-/- littermates and rotarod endurance test of untreated and NtBuHA-treated Ppt1-/- mice.
b
c
V2ML
a
Corpus callosum
60 µm
WTUntreated Ppt1-/-
NtBuHA-treated Ppt1-/-
0100200300400500600700800
Cor
tical
thic
knes
s (µ
m)
P<0.0001P<0.0001
WTUntreated Ppt1-/-
NtBuHA-treated Ppt1-/-
Supplementary data Fig. 9 The sections of the brain from 6-month old WT (n= 4), untreated Ppt1-/-
(n=4) and NtBuHA-treated Ppt1-/- (n=4) mice were stained with cresyl violet and photomicrographs were analyzed for cortical thickness (a). Graphic representation of the brain region (V2ML, secondary visual cortex mediolateral) where the cortical thickness was measured (Arrow); (b) cresyl violet stained cortical sections from WT, untreated- and NtBuHA-treated Ppt1-/- mice; (c) graphic representation of the cortical thickness among WT mice and their untreated- and NtBuHA-treated littermates. The results are presented as the mean + SD; (d) Three-month old WT (n=6) and Ppt1-/- mice (n=6) were tested on rotarod at 4, 8 and 12 rpm for 60 seconds. No significant difference in motor coordination was observed at this age between WT and Ppt1-/- mice; (e) Six-months old WT (n= 6), untreated Ppt1-/- (n=8) and NtBuHA-treated Ppt1-/- (n=7) mice were allowed to stay on rotarod at 12 rpm for up to 300 seconds. Note a significant, albeit modest, improvement in performance of NtBuHA-treated Ppt1-/- mice in the rotarod endurance test.
0
50
100
150
200
250
300
350
Tim
e on
rot
arod
(s)
P<0.001
P<0.001
WT Untreated Ppt1-/-
NtBuHA-treated Ppt1-/-
0
10
20
30
40
50
60
70
RPM
Tim
e on
rot
arod
(s)
WT
Ppt1-/-
4 8 12
ed
Nature Neuroscience: doi:10.1038/nn.3526
kDa250
130 100
7055
35
25
15
kDa250
130 100
7055
35
25
15
kDa100
70
55
35
Supplementary Fig. 10 Full length pictures of the cropped blots presented in the mainfigures: 4e and 5e .
kDa250
130 100
7055
3525
1510
kDa250
130 100
7055
3525
1510
kDa250
130 100
7055
3525
1510
1 2 3 1 2 3 1 2 3
WTUntreated PPT1-/-
NtBuHA-treated PPT1-/-
CleavedCaspase-9
ß-Actin
Cleaved PARP-1
a b
1 2 3 1 2 3 1 2 3
WTUntreated PPT1-/-
NtBuHA-treated PPT1-/-
NeuN
GFAP
ß-Actin
Supplementary data Fig. 10: panel a, full length picture of the cropped gel in main Figure 4e; panel b, full length picture of the cropped gel in main Figure 5e.
Nature Neuroscience: doi:10.1038/nn.3526
Supplemenary Table 1: Hydroxylamine and its Derivatives
Chemical Formula Description
NH2OH · HCl Hydroxylamine hydrochloride
1. C6H15NO3 N-(tert-Butyl)hydroxylamine acetate
2. C7H9NO · HCl N-Benzylhydroxylamine hydrochloride
3. CH5NO · HCl N-Methylhydroxylamine hydrochloride
4. C6H13NO · HCl N-Cyclohexylhydroxylamine hydrochloride
5. C2H7NO · HCl N,N-Dimethylhydroxylamine hydrochloride
6. C4H11NO N,N-Diethylhydroxylamine
7. C6H19NOSi2 N,O-Bis(trimethylsilyl) hydroxylamine
8. C8H9NO3 N-Benzyloxycarbonyl hydroxylamine
9. C14H15NO N,N-Dibenzylhydroxylamine
10. C13H11NO2 N-Benzoyl-N-phenyl hydroxylamine
11. C23H32ClNO N-tert-Butyl-O-[1-[4-(chloromethyl) phenyl]ethyl]- N-(2-methyl-1-phenylpropyl) hydroxylamine
12. C10H19NO5 N,O-Di-Boc-hydroxylamine
Nature Neuroscience: doi:10.1038/nn.3526
Supplementary Table 2: PPT1-deficient cell lines from INCL patients
Cell line PPT1-mutations
Lymphoblasts*
1. C11568 MissenseMissense
A364T (R122W)G541A (V181M)
2. C12275 MissenseNonsense
G353A (G118D)C451T (R151X)
3. C11796 NonsenseNonsense
C451T (R151X)C451T (R151X)
4. C10949 NonsenseNonsense
C490T (R161X)C490T (R161X)
5. C1045LT NonsenseNonsense
C451T (R151X)C451T (R151X)
6. C7142L NonsenseMissense
C451T (R151X)G541A (V181M)
7. C10320LT NonsenseMissense
C451T (R151X)G749T (G250V)
8. C11560 MissenseNonsense
A223C (T75P)C451T (R151X)
9. C12488 MissenseMissense
A223C (T75P)A223C (T75P)
10.
C9982 (N1) Normal lymphoblasts (NL)
Fibroblasts
INCL Fibroblasts MissenseMissense
A364T (R122W)A364T (R122W)
* All lymphoblasts and their genotypes were generously provided by Late Dr. K.E. Wisniewski.
11.
GM00131(N2) Normal lymphoblasts (NL)
12.
GM00536 (N3) Normal lymphoblasts (NL)
13.
C9955 (N4) Normal lymphoblasts (NL)
Nature Neuroscience: doi:10.1038/nn.3526
Supplemental Video: Rotarod Test
Rotarod test (60 seconds) in WT, untreated Ppt1-/- and NtBuHA-treated Ppt1-/- mice. Mouse#1 & 2 (left), NtBuHA-treated; Mouse #3 & 4 (middle), untreated and Mouse#5 (right), WT.
Nature Neuroscience: doi:10.1038/nn.3526
Recommended